New hope for pancreatic cancer: experimental combo enters phase 3 trial
NCT ID NCT07562152
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This phase 3 study tests whether adding the experimental drug atebimetinib to a modified chemotherapy regimen helps people with metastatic pancreatic cancer live longer compared to standard chemotherapy alone. About 510 adults who have not had prior treatment for their advanced pancreatic cancer will participate. The study measures overall survival, tumor shrinkage, and disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGPhoenix, Arizona, 85338, United States
Contact Email: •••••@•••••
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
-
City of Hope
RECRUITINGChicago, Illinois, 60099, United States
Contact
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Email: •••••@•••••
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
Contact Email: •••••@•••••
-
Taylor Cancer Research Center
RECRUITINGMaumee, Ohio, 43537, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.